title: Dabigatran etexilate: another double-edged drug? : editorial to: "the beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice" by N. Kadoglou et al.
authors.forename: Juan C
authors.initials: JC
authors.lastname: Laguna
authors.forename: Marta
authors.initials: M
authors.lastname: Alegret
mesh_terms: D000818:Animals; D000991:Antithrombins / Q000627:therapeutic use*; D050197:Atherosclerosis / Q000188:drug therapy*; D001562:Benzimidazoles / Q000627:therapeutic use*; D000069604:Dabigatran; D008297:Male; D051379:Mice; D011725:Pyridines / Q000627:therapeutic use*
chemical_list: D000991:Antithrombins; D001562:Benzimidazoles; D011725:Pyridines; D000069604:Dabigatran